COMT inhibitors, such as tolcapone and entacapone, block the enzymatic breakdown of dopamine by the catechol-O-methyltransferase enzyme. These drugs commonly are given in conjunction with the combination of levodopa and carbidopa, since they inhibit COMT degradation of levodopa in peripheral tissues, thereby increasing levodopa’s half-life…
Read More